Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare. The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry. Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.

Share:
More In Science
Apple Watch Alerts Woman to Blood Clot
A 29-year-old Cincinnati woman was awakened by her Apple Watch, which alerted her about an elevated heart rate, prompting her to head to a doctor who notified her of a blood clot.
Florida County Under Quarantine Over Snails
A quarantine is in place for a section of Broward county in Florida due to a rise in African land snails, which are harmful to agriculture and can eat their way through about 500 plant species.
Cheddar Reports: Montana Kids Suing State Over Climate Change 
Climate change is on trial in Montana. In a landmark case, 16 young people are suing the state over effects like smoke, heat, and drought. It's just the first in a series of cases intended to pressure lawmakers into taking action on the environment. Here with more is Cheddar News Senior Reporter Chloe Aiello.
Cheddar Reports: How El Niño Could Affect You This Summer
It's only June and already scientists are saying it could be the hottest year on record, as the warming effects of El Niño will continue to strengthen into the fall and winter. Here with more is Cheddar News Senior Reporter Chloe Aiello.
Load More